Journal
CA-A CANCER JOURNAL FOR CLINICIANS
Volume 52, Issue 3, Pages 154-179Publisher
WILEY
DOI: 10.3322/canjclin.52.3.154
Keywords
-
Categories
Ask authors/readers for more resources
Androgen deprivation therapy remains a mainstay of treatment for men with prostate cancer. New uses for hormonal therapy, including use in the adjuvant and neoadjuvant setting, are being evaluated. Prevention of the side effects of therapy has led to the development of alternative schedules and therapeutics.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
